Are your clients asking you about psychedelics? Are you interested into where this field is headed?
Psilocybin is generating significant clinical interest. Nearly 150 clinical trials, spanning more than 50 potential indications, are currently underway worldwide, and your clients may be exploring options independently.
This webinar provides the context you need - grounded in neuroscience and clinical evidence - to support informed conversations. We'll also have an open Q&A afterwards for you to ask any questions you may have on psilocybin and our approach.
What You'll Learn:
- Neuroscience of psilocybin
- What indications research is showing it's effective for
- How does psilocybin work in relationship with talk therapy
- Current state of legality - where it's legal, options that are available, and what is on the horizon
- Our program structure and the role of set and setting at a retreat vs. a clinical setting
- Who our retreats are best suited for and who they aren't
- Q&A with Beckley Retreats
Our Speakers
Ben Sheinwald
Biodynamic Therapist, Lead Facilitator at Beckley Retreats
Fede Menapace
Chief Growth Officer, Beckley Retreats, Former COO at MAPS
Beckley Retreats Was Featured In
Beckley Retreats Team Member Affiliations